Unipath

Unipath Specialty Laboratory is an established Indian multi-specialty pathology and clinical laboratory chain offering comprehensive diagnostic testing across molecular biology, cytopathology, biochemistry, serology, immunology, hematopathology, flow cytometry, cytogenetics, microbiology and toxicology. The company has expanded both organically and inorganically in recent years—including the acquisition of Simira Diagnostics in February 2024—and invested significantly in advanced technologies such as Next Generation Sequencing. It operates over forty labs across India with strong presence in Gujarat and growing reach into other states. The business is accredited by NABL and ISO certified for quality management systems.[2][5][6]